Diagnosis and Management of Metastatic Cervical Spine Tumors

Orthopedic Clinics of North America

Volumn 43, Issue 1, 2012, Pages 75-87

  Molina, Camilo A ^a   Gokaslan, Ziya L ^a   Sciubba, Daniel M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cervical spine tumors; Metastasis; Palliative therapy; Vertebrectomy

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; DEXAMETHASONE; STEROID;

AGE; ARTERY INJURY; BONE BIOPSY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CARCINOGENESIS; CEREBROSPINAL FLUID; CERVICOBRACHIAL NEURALGIA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG SAFETY; EARLY DIAGNOSIS; ESOPHAGUS INJURY; HUMAN; LAMINECTOMY; LIFE EXPECTANCY; LIQUORRHEA; LOW DRUG DOSE; NECK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SPINAL CORD COMPRESSION; SPINAL CORD METASTASIS; SPINE SURGERY; STEREOTAXIC SURGERY; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR SEEDING; UNSPECIFIED SIDE EFFECT; VERTEBRAL ARTERY; VERTEBRECTOMY;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CERVICAL VERTEBRAE; DECOMPRESSION, SURGICAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LAMINECTOMY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PALLIATIVE CARE; PATIENT SELECTION; PREOPERATIVE CARE; PROGNOSIS; RISK ASSESSMENT; SPINAL FUSION; SPINAL NEOPLASMS; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 82655173218     PISSN: 00305898     EISSN: 15581373     Source Type: Journal    
DOI: 10.1016/j.ocl.2011.08.004     Document Type: Review

References (83)

1. Marchesi D.G., Boos N., Aebi M. Surgical treatment of tumors of the cervical spine and first two thoracic vertebrae. J Spinal Disord 1993, 6(6):489-496.
2. Fehlings M.G., David K.S., Vialle L., et al. Decision making in the surgical treatment of cervical spine metastases. Spine (Phila Pa 1976) 2009, 34(Suppl 22):S108-S117.
3. Cancer facts and figures 2005 2005, American Cancer Society, Atlanta.
4. Sciubba D.M., Petteys R.J., Dekutoski M.B., et al. Diagnosis and management of metastatic spine disease. J Neurosurg Spine 2010, 13(1):94-108.
5. Molina C.A., Gokaslan Z.L., Sciubba D.M. Spinal tumors. Primary Central Nervous System Tumors 2011, 529. Humana Press. A.D. Norden, D.A. Reardon, P.C. Wen (Eds.).
6. Cloyd J.M., Chou D., Deviren V., et al. En bloc resection of primary tumors of the cervical spine: report of two cases and systematic review of the literature. Spine J 2009, 9(11):928-935.
7. Chaichana K.L., Pendleton C., Sciubba D.M., et al. Outcome following decompressive surgery for different histological types of metastatic tumors causing epidural spinal cord compression. Clinical article. J Neurosurg Spine 2009, 11(1):56-63.
8. Chaichana K.L., Pendleton C., Wolinsky J.P., et al. Vertebral compression fractures in patients presenting with metastatic epidural spinal cord compression. Neurosurgery 2009, 65(2):267. 274 [discussion: 274-5].
9. Cybulski G.R. Methods of surgical stabilization for metastatic disease of the spine. Neurosurgery 1989, 25(2):240-252.
10. York J.E., Wildrick D.M., Gokaslan Z.L. Metastatic tumors. The Thoracic Spine 1999, 392-411. Quality Medical Publishing, St Louis. E.C. Benzel, C.B. Stillerman (Eds.).
11. Jenis L.G., Dunn E.J., An H.S. Metastatic disease of the cervical spine. A review. Clin Orthop Relat Res 1999, (359):89-103.
12. Moulding H.D., Bilsky M.H. Metastases to the craniovertebral junction. Neurosurgery 2010, 66(Suppl 3):113-118.
13. Arguello F., Baggs R.B., Duerst R.E., et al. Pathogenesis of vertebral metastasis and epidural spinal cord compression. Cancer 1990, 65(1):98-106.
14. Rao S., Badani K., Schildhauer T., et al. Metastatic malignancy of the cervical spine. A nonoperative history. Spine (Phila Pa 1976) 1992, 17(Suppl 10):S407-S412.
15. Denaro V., Di Martino A., Papalia R., et al. Patients with cervical metastasis and neoplastic pachymeningitis are less likely to improve neurologically after surgery. Clin Orthop Relat Res 2011, 469(3):708-714.
16. Mazel C., Balabaud L., Bennis S., et al. Cervical and thoracic spine tumor management: surgical indications, techniques, and outcomes. Orthop Clin North Am 2009, 40(1):75. 92, vi-vii.
17. Sundaresan N., Krol G., DiGiacinto G. Metastatic tumors of the spine. Tumors of the Spine. Diagnosis and Clinical Management 1990, WB Saunders, Philadelphia. N. Sundaresan, H. Schmidek, A. Schiller (Eds.).
18. Sundaresan N., Boriani S., Rothman A., et al. Tumors of the osseous spine. J Neurooncol 2004, 69(1-3):273-290.
19. Sherk H.H. Lesions of the atlas and axis. Clin Orthop Relat Res 1975, (109):33-41.
20. George B., Lot G., Velut S., et al. French Language Society of Neurosurgery. 44th Annual Congress. Brussels, 8-12 June 1993. Tumors of the foramen magnum. Neurochirurgie 1993, 39(Suppl 1):1-89.
21. Phillips E., Levine A.M. Metastatic lesions of the upper cervical spine. Spine (Phila Pa 1976) 1989, 14(10):1071-1077.
22. Ono K., Tada K. Metal prosthesis of the cervical vertebra. J Neurosurg 1975, 42(5):562-566.
23. Sciubba D.M., Gokaslan Z.L. Diagnosis and management of metastatic spine disease. Surg Oncol 2006, 15(3):141-151.
24. Dickman C.A., Spetzler R.F., Sonntag V.K. Surgery of the craniovertebral junction 1998, Thieme, New York.
25. An H.S., Vaccaro A.R., Dolinskas C.A., et al. Differentiation between spinal tumors and infections with magnetic resonance imaging. Spine (Phila Pa 1976) 1991, 16(Suppl 8):S334-S338.
26. Tomita T., Galicich J.H., Sundaresan N. Radiation therapy for spinal epidural metastases with complete block. Acta Radiol Oncol 1983, 22(2):135-143.
27. Donthineni R. Diagnosis and staging of spine tumors. Orthop Clin North Am 2009, 40(1):1. 7, v.
28. Sciubba D.M., Gallia G.L., McGirt M.J., et al. Thoracic kyphotic deformity reduction with a distractible titanium cage via an entirely posterior approach. Neurosurgery 2007, 60(4):223. 230 [discussion: 230-1].
29. Tokuhashi Y., Matsuzaki H., Toriyama S., et al. Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine 1990, 15(11):1110-1113.
30. Harrington K.D. The use of methylmethacrylate for vertebral-body replacement and anterior stabilization of pathological fracture-dislocations of the spine due to metastatic malignant disease. J Bone Joint Surg Am 1981, 63(1):36-46.
31. Kostuik J., Weinstein J. Differential diagnosis and surgical treatment of metastatic spine tumors. The Adult Spine: Principles and Practice 1991, 861-888. Raven Press, New York. J. Frymoyer (Ed.).
32. DeWald R.L., Bridwell K.H., Prodromas C., et al. Reconstructive spinal surgery as palliation for metastatic malignancies of the spine. Spine (Phila Pa 1976) 1985, 10(1):21-26.
33. Boriani S., Weinstein J. Differential diagnosis and surgical treatment of primary benign and malignant neoplasms. The adult spine: principles and practice 1997, 951-987. Lippincott-Raven, Philadelphia. J. Frymoyer (Ed.).
34. Tomita K., Kawahara N., Baba H., et al. Total en bloc spondylectomy. A new surgical technique for primary malignant vertebral tumors. Spine (Phila Pa 1976) 1997, 22(3):324-333.
35. Tokuhashi Y., Matsuzaki H., Oda H., et al. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005, 30(19):2186-2191.
36. Rades D., Huttenlocher S., Dunst J., et al. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. J Clin Oncol 2010, 28(22):3597-3604.
37. Kijima T., Fujii Y., Suyama T., et al. Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate. BJU Int 2009, 103(5):620-624.
38. Niang U., Kamer S., Ozsaran Z., et al. The management of painful bone metastases with bisphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases. J BUON 2009, 14(2):245-249.
39. Rades D., Lange M., Veninga T., et al. Preliminary results of spinal cord compression recurrence evaluation (score-1) study comparing short-course versus long-course radiotherapy for local control of malignant epidural spinal cord compression. Int J Radiat Oncol Biol Phys 2009, 73(1):228-234.
40. Rose P.S., Laufer I., Boland P.J., et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J Clin Oncol 2009, 27(30):5075-5079.
41. Wowra B., Muacevic A., Zausinger S., et al. Radiosurgery for spinal malignant tumors. Dtsch Arztebl Int 2009, 106(7):106-112.
42. Kaasa S., Brenne E., Lund J.A., et al. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy × 1) versus multiple fractions (3 Gy × 10) in the treatment of painful bone metastases. Radiother Oncol 2006, 79(3):278-284.
43. Nielsen O.S., Bentzen S.M., Sandberg E., et al. Randomized trial of single dose versus fractionated palliative radiotherapy of bone metastases. Radiother Oncol 1998, 47(3):233-240.
44. Maranzano E., Bellavita R., Rossi R., et al. Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. J Clin Oncol 2005, 23(15):3358-3365.
45. Patchell R.A., Tibbs P.A., Regine W.F., et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005, 366(9486):643-648.
46. Gerszten P.C., Burton S.A., Ozhasoglu C., et al. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 2007, 32(2):193-199.
47. Gibbs I.C., Kamnerdsupaphon P., Ryu M.R., et al. Image-guided robotic radiosurgery for spinal metastases. Radiother Oncol 2007, 82(2):185-190.
48. Vecht C.J., Haaxma-Reiche H., van Putten W.L., et al. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 1989, 39(9):1255-1257.
49. Heimdal K., Hirschberg H., Slettebo H., et al. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol 1992, 12(2):141-144.
50. Harel R., Angelov L. Spine metastases: current treatments and future directions. Eur J Cancer 2010, 46(15):2696-2707.
51. Amato R.J., Hernandez-McClain J., Henary H. Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer. Am J Clin Oncol 2008, 31(6):532-538.
52. Kattan J.G., Farhat F.S., Chahine G.Y., et al. Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC). Invest New Drugs 2008, 26(1):75-79.
53. Lin A.M., Rini B.I., Derynck M.K., et al. A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer. Clin Genitourin Cancer 2007, 5(5):323-328.
54. Cazzaniga M.E., Dogliotti L., Cascinu S., et al. Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study. Oncology 2006, 71(5-6):374-381.
55. Beer T.M., Garzotto M., Henner W.D., et al. Intermittent chemotherapy in metastatic androgen-independent prostate cancer. Br J Cancer 2003, 89(6):968-970.
56. Daliani D.D., Assikis V., Tu S.M., et al. Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma. Cancer 2003, 97(3):561-567.
57. Amir E., Ooi W.S., Simmons C., et al. Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies. Clin Oncol (R Coll Radiol) 2008, 20(10):763-768.
58. Lipton A., Steger G.G., Figueroa J., et al. Extended efficacy and safety of denosumab in breast cancer patients with bone metastases not receiving prior bisphosphonate therapy. Clin Cancer Res 2008, 14(20):6690-6696.
59. Paridaens R.J., Dirix L.Y., Beex L.V., et al. Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group. J Clin Oncol 2008, 26(30):4883-4890.
60. Nagata M., Ueda T., Komiya A., et al. Treatment and prognosis of patients with paraplegia or quadriplegia because of metastatic spinal cord compression in prostate cancer. Prostate Cancer Prostatic Dis 2003, 6(2):169-173.
61. Zafeirakis A., Papatheodorou G., Arhontakis A., et al. Predictive implications of bone turnover markers after palliative treatment with (186)Re-HEDP in hormone-refractory prostate cancer patients with painful osseous metastases. Eur J Nucl Med Mol Imaging 2010, 37(1):103-113.
62. Paterson A.H., Powles T.J., Kanis J.A., et al. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 1993, 11(1):59-65.
63. Kristensen B., Ejlertsen B., Mouridsen H.T., et al. Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer. Acta Oncol 2008, 47(4):740-746.
64. Hortobagyi G.N., Theriault R.L., Porter L., et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. N Engl J Med 1996, 335(24):1785-1791.
65. Lipton A., Theriault R.L., Hortobagyi G.N., et al. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer 2000, 88(5):1082-1090.
66. Rosen L.S., Gordon D., Kaminski M., et al. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial. Cancer 2003, 98(8):1735-1744.
67. Rosen L.S., Gordon D., Tchekmedyian S., et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial-the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 2003, 21(16):3150-3157.
68. Saad F., Gleason D.M., Murray R., et al. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 2004, 96(11):879-882.
69. Hoshino Y., Kurokawa T., Nakamura K., et al. A report on the safety of unilateral vertebral artery ligation during cervical spine surgery. Spine (Phila Pa 1976) 1996, 21(12):1454-1457.
70. Ibrahim A., Crockard A., Antonietti P., et al. Does spinal surgery improve the quality of life for those with extradural (spinal) osseous metastases? An international multicenter prospective observational study of 223 patients. J Neurosurg Spine 2008, 8(3):271-278.
71. Quan G.M., Vital J.M., Pointillart V. Outcomes of palliative surgery in metastatic disease of the cervical and cervicothoracic spine. J Neurosurg Spine 2011, 14(5):612-618.
72. Atanasiu J.P., Badatcheff F., Pidhorz L. Metastatic lesions of the cervical spine. A retrospective analysis of 20 cases. Spine (Phila Pa 1976) 1993, 18(10):1279-1284.
73. Caspar W., Pitzen T., Papavero L., et al. Anterior cervical plating for the treatment of neoplasms in the cervical vertebrae. J Neurosurg 1999, 90(Suppl 1):27-34.
74. Chuang H.C., Wei S.T., Lee H.C., et al. Preliminary experience of titanium mesh cages for pathological fracture of middle and lower cervical vertebrae. J Clin Neurosci 2008, 15(11):1210-1215.
75. Heidecke V., Rainov N.G., Burkert W. Results and outcome of neurosurgical treatment for extradural metastases in the cervical spine. Acta Neurochir (Wien) 2003, 145(10):873. 880. [discussion: 880-1].
76. Jonsson B., Jonsson H., Karlstrom G., et al. Surgery of cervical spine metastases: a retrospective study. Eur Spine J 1994, 3(2):76-83.
77. Liu J.K., Rosenberg W.S., Schmidt M.H. Titanium cage-assisted polymethylmethacrylate reconstruction for cervical spinal metastasis: technical note. Neurosurgery 2005, 56(Suppl 1):E207. [discussion: E207].
78. Mazel C., Hoffmann E., Antonietti P., et al. Posterior cervicothoracic instrumentation in spine tumors. Spine (Phila Pa 1976) 2004, 29(11):1246-1253.
79. Oda I., Abumi K., Ito M., et al. Palliative spinal reconstruction using cervical pedicle screws for metastatic lesions of the spine: a retrospective analysis of 32 cases. Spine (Phila Pa 1976) 2006, 31(13):1439-1444.
80. Omeis I., Bekelis K., Gregory A., et al. The use of expandable cages in patients undergoing multilevel corpectomies for metastatic tumors in the cervical spine. Orthopedics 2010, 33(2):87-92.
81. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85(5):365-376.
82. Hart R.A., Boriani S., Biagini R., et al. A system for surgical staging and management of spine tumors. A clinical outcome study of giant cell tumors of the spine. Spine (Phila Pa 1976) 1997, 22(15):1773. 1782 [discussion: 1783].
83. Miller D.J., Lang F.F., Walsh G.L., et al. Coaxial double-lumen methylmethacrylate reconstruction in the anterior cervical and upper thoracic spine after tumor resection. J Neurosurg 2000, 92(Suppl 2):181-190.